Physician profile
Peter G Hamm
NPI 1457334401
$7,976.95
in general payments reported to CMS, 2019-2025
43 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,742 · 2020: $1,075 · 2021: $1,002 · 2022: $1,694 · 2023: $1,470 · 2024: $994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,442 · Education: $22.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,441.64 |
| Education | $22.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,915.93 | 2019-2024 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,618.84 | 2019-2024 | Tezspire, Fasenra, Airsupra |
| Insmed, INC. | $856.41 | 2019-2024 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $405.10 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $336.47 | 2021-2023 | Dupixent |
| Grifols USA, LLC | $296.65 | 2019-2024 | Prolastin-C Liquid |
| Genzyme Corporation | $253.16 | 2019-2024 | |
| Mylan Specialty L.P. | $251.58 | 2020-2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $213.47 | 2019-2024 | Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $194.51 | 2019-2024 | |
| Mallinckrodt Hospital Products INC. | $169.34 | 2021-2022 | |
| Genentech USA, INC. | $120.39 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $115.14 | 2019-2023 | Xarelto |
| Shionogi INC | $107.55 | 2024 | Fetroja |
| E.R. Squibb & Sons, L.L.C. | $86.45 | 2019-2023 | Eliquis |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $86.22 | 2019-2023 | Tezspire |
| Electromed, INC. | $82.36 | 2019-2024 | Smartvest |
| Vapotherm INC | $72.64 | 2022 | |
| Paratek Pharmaceuticals, INC. | $66.55 | 2022 | |
| Daiichi Sankyo INC. | $63.27 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $59.18 | 2019-2020 | |
| Inogen, INC. | $53.46 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Astellas Pharma US INC | $47.67 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.07 | 2020-2023 | Cuvitru |
| Inspire Medical Systems, INC. | $44.10 | 2023 | Inspire |
| Sanofi Pasteur INC. | $36.47 | 2019 | |
| Mallinckrodt Enterprises LLC | $30.39 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $28.00 | 2020-2022 | |
| Pfizer INC. | $26.61 | 2024 | |
| Axsome Therapeutics, INC. | $26.17 | 2024 | Sunosi |
| Advanced Respiratory, INC | $25.08 | 2020 | |
| Monaghan Medical Corporation | $24.86 | 2024 | Aerobika |
| Novartis Pharmaceuticals Corporation | $24.28 | 2021 | |
| Jazz Pharmaceuticals INC. | $23.41 | 2021 | |
| United Therapeutics Corporation | $22.79 | 2022 | |
| Pulmonx Corporation | $22.44 | 2023 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Biomerieux INC | $21.44 | 2020 | |
| Exact Sciences Corporation | $21.20 | 2023 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $19.41 | 2019 | |
| Resmed Corp | $18.81 | 2019 | |
| Circassia INC. | $18.56 | 2020 | |
| Sunovion Pharmaceuticals INC. | $12.87 | 2019 | |
| Novo Nordisk INC | $12.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Hamm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.